论文部分内容阅读
目的观察艾迪注射液联合放化疗治疗老年晚期恶性肿瘤患者的临床疗效。方法经病理学确诊的老年晚期恶性肿瘤患者68例,随机分为对照组和治疗组,各34例,对照组仅使用放疗或化疗,治疗组加用艾迪注射液,比较两组抗肿瘤疗效、患者生活质量和血象变化等指标。结果治疗组抗肿瘤疗效、患者生活质量和血象变化等指标与对照组比较,均有明显改善,差异具有统计学意义(P<0.05)。结论艾迪注射液可以显著提高老年恶性肿瘤患者放化疗的近期疗效,明显改善患者的生活质量,也可以减轻放化疗的毒副反应,值得推广。
Objective To observe the clinical effect of Aidi injection combined with radiotherapy and chemotherapy in the treatment of elderly patients with advanced malignant tumor. Methods Sixty-eight patients with advanced malignant neoplasm diagnosed by pathology were randomly divided into control group and treatment group, with 34 cases in each group. The control group only used radiotherapy or chemotherapy. The treatment group was given Aidi Injection. The antitumor efficacy was compared between the two groups , Quality of life of patients and blood changes and other indicators. Results The anti-tumor efficacy, quality of life and blood changes in the treatment group were significantly improved compared with the control group, the difference was statistically significant (P <0.05). Conclusion Aidi injection can significantly improve the long-term efficacy of radiotherapy and chemotherapy in elderly patients with malignant tumors, significantly improve the quality of life of patients, and can reduce the side effects of radiotherapy and chemotherapy, which is worth promoting.